Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
A Family Paradise Awaits at Grand Park Kodhipparu, Maldives
MALÉ, Maldives, June 7, 2025 /PRNewswire/ -- This summer, create cherished memories…
